ARKADY NISMAN, PHARMD

Articles by ARKADY NISMAN, PHARMD

A Further Look at Rational Polytherapy in Patients With Uncontrolled Epilepsy: Insights From a Post hoc Analysis of Adjunctive Cenobamate

ByLOUIS FERRARI, MBA, RPH,ARKADY NISMAN, PHARMD

December 21st 2021

Increasing Awareness and Counseling on the Importance of Titration Schedules

ByLou Ferrari, RPh, MBA,ARKADY NISMAN, PHARMD,Rolando J. Veloso, PharmD

March 5th 2021

The Evolving Epilepsy Treatment Spectrum: A Review of Antiepileptic Drugs in Late Development

ByBY LOUIS FERRARI, MBA, RPH,JEONG WOO CHO, PHD,ARKADY NISMAN, PHARMD

October 29th 2019

Given the relatively static rate of seizure freedom with the current antiepileptic drug (AED) armamentarium, a need remains for the development of new compounds to help enable more patients achieve seizure freedom. Fortunately, several investigational therapeutic agents and delivery systems are in phase 3 development, which are being investigated for the treatment of orphan diseases and focal-onset and generalized-onset seizures.